Class information for:
Level 2: GLUCAGON LIKE PEPTIDE 1//GLP 1//INCRETIN

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
1167 9383 43.2 82%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
176 3       DIABETES CARE//ENDOCRINOLOGY & METABOLISM//TYPE 2 DIABETES 58057
1167 2             GLUCAGON LIKE PEPTIDE 1//GLP 1//INCRETIN 9383
376 1                   GLUCAGON LIKE PEPTIDE 1//GLP 1//INCRETIN 3566
580 1                   DPP 4 INHIBITOR//EXENATIDE//LIRAGLUTIDE 3286
9043 1                   SGLT2 INHIBITOR//DAPAGLIFLOZIN//CANAGLIFLOZIN 1193
15285 1                   GPR40//GPR120//GPR119 721
17101 1                   GLUCAGON RECEPTOR//GLUCAGON RECEPTOR ANTAGONIST//GLUCAGON ANTAGONIST 617

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 GLUCAGON LIKE PEPTIDE 1 authKW 1292863 8% 54% 736
2 GLP 1 authKW 1164002 7% 52% 687
3 INCRETIN authKW 1079748 6% 63% 531
4 LIRAGLUTIDE authKW 865265 4% 76% 351
5 EXENATIDE authKW 845648 4% 75% 347
6 DPP 4 INHIBITOR authKW 773503 3% 77% 310
7 SGLT2 INHIBITOR authKW 771011 3% 94% 253
8 DIPEPTIDYL PEPTIDASE 4 INHIBITOR authKW 596617 3% 78% 235
9 SITAGLIPTIN authKW 574550 3% 63% 282
10 DAPAGLIFLOZIN authKW 448463 2% 93% 149

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Endocrinology & Metabolism 118975 43% 1% 4068
2 Pharmacology & Pharmacy 7064 18% 0% 1693
3 Physiology 2389 6% 0% 605
4 Medicine, Research & Experimental 1787 6% 0% 590
5 Medicine, General & Internal 1338 7% 0% 674
6 Chemistry, Medicinal 1007 4% 0% 360
7 Gastroenterology & Hepatology 661 3% 0% 315
8 Biochemistry & Molecular Biology 636 12% 0% 1091
9 Nutrition & Dietetics 385 2% 0% 219
10 Cardiac & Cardiovascular System 318 4% 0% 343

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 SAAD PHARM DIABET 84756 1% 47% 55
2 BANTING BEST DIABET 81390 1% 29% 87
3 NNF BASIC METAB 75039 1% 42% 55
4 PANUM 67955 3% 8% 272
5 INTERNAL MED F 47578 1% 26% 56
6 THER EUT AREA METAB 42281 0% 100% 13
7 DIABET 36941 3% 4% 327
8 LILLY DIABET 36191 0% 70% 16
9 DIABET NUTR METAB DISORDERS 29628 0% 25% 37
10 DIABET CLIN NUTR ENDOCRINOL 27705 0% 61% 14

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 DIABETES OBESITY & METABOLISM 335928 5% 22% 477
2 DIABETES THERAPY 87962 1% 39% 70
3 JOURNAL OF DIABETES INVESTIGATION 52334 1% 17% 96
4 CARDIOVASCULAR DIABETOLOGY 25112 1% 8% 98
5 DIABETES 20412 3% 2% 277
6 DIABETES CARE 18332 3% 2% 256
7 DIABETOLOGIA 15073 2% 2% 198
8 REGULATORY PEPTIDES 12159 1% 3% 134
9 AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM 8773 1% 2% 134
10 DIABETES & VASCULAR DISEASE RESEARCH 7208 0% 7% 30

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 GLUCAGON LIKE PEPTIDE 1 1292863 8% 54% 736 Search GLUCAGON+LIKE+PEPTIDE+1 Search GLUCAGON+LIKE+PEPTIDE+1
2 GLP 1 1164002 7% 52% 687 Search GLP+1 Search GLP+1
3 INCRETIN 1079748 6% 63% 531 Search INCRETIN Search INCRETIN
4 LIRAGLUTIDE 865265 4% 76% 351 Search LIRAGLUTIDE Search LIRAGLUTIDE
5 EXENATIDE 845648 4% 75% 347 Search EXENATIDE Search EXENATIDE
6 DPP 4 INHIBITOR 773503 3% 77% 310 Search DPP+4+INHIBITOR Search DPP+4+INHIBITOR
7 SGLT2 INHIBITOR 771011 3% 94% 253 Search SGLT2+INHIBITOR Search SGLT2+INHIBITOR
8 DIPEPTIDYL PEPTIDASE 4 INHIBITOR 596617 3% 78% 235 Search DIPEPTIDYL+PEPTIDASE+4+INHIBITOR Search DIPEPTIDYL+PEPTIDASE+4+INHIBITOR
9 SITAGLIPTIN 574550 3% 63% 282 Search SITAGLIPTIN Search SITAGLIPTIN
10 DAPAGLIFLOZIN 448463 2% 93% 149 Search DAPAGLIFLOZIN Search DAPAGLIFLOZIN

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 HOLST, JJ , (2007) THE PHYSIOLOGY OF GLUCAGON-LIKE PEPTIDE 1.PHYSIOLOGICAL REVIEWS. VOL. 87. ISSUE 4. P. 1409 -1439 259 85% 952
2 KIM, W , EGAN, JM , (2008) THE ROLE OF INCRETINS IN GLUCOSE HOMEOSTASIS AND DIABETES TREATMENT.PHARMACOLOGICAL REVIEWS. VOL. 60. ISSUE 4. P. 470 -512 364 74% 260
3 BAGGIO, LL , DRUCKER, DJ , (2007) BIOLOGY OF INCRETINS: GLP-1 AND GIP.GASTROENTEROLOGY. VOL. 132. ISSUE 6. P. 2131 -2157 188 82% 1270
4 CHO, YM , MERCHANT, CE , KIEFFER, TJ , (2012) TARGETING THE GLUCAGON RECEPTOR FAMILY FOR DIABETES AND OBESITY THERAPY.PHARMACOLOGY & THERAPEUTICS. VOL. 135. ISSUE 3. P. 247 -278 377 77% 34
5 MILLIGAN, G , SHIMPUKADE, B , ULVEN, T , HUDSON, BD , (2017) COMPLEX PHARMACOLOGY OF FREE FATTY ACID RECEPTORS.CHEMICAL REVIEWS. VOL. 117. ISSUE 1. P. 67 -110 221 60% 2
6 KIEFFER, TJ , HABENER, JL , (1999) THE GLUCAGON-LIKE PEPTIDES.ENDOCRINE REVIEWS. VOL. 20. ISSUE 6. P. 876 -913 348 71% 647
7 DE GRAAF, C , DONNELLY, D , WOOTTEN, D , LAU, J , SEXTON, PM , MILLER, LJ , AHN, JM , LIAO, JY , FLETCHER, MM , YANG, DH , ET AL (2016) GLUCAGON-LIKE PEPTIDE-1 AND ITS CLASS B G PROTEIN-COUPLED RECEPTORS: A LONG MARCH TO THERAPEUTIC SUCCESSES.PHARMACOLOGICAL REVIEWS. VOL. 68. ISSUE 4. P. 954 -1013 351 70% 0
8 SCHEEN, AJ , (2015) PHARMACODYNAMICS, EFFICACY AND SAFETY OF SODIUM-GLUCOSE CO-TRANSPORTER TYPE 2 (SGLT2) INHIBITORS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS.DRUGS. VOL. 75. ISSUE 1. P. 33 -59 133 97% 43
9 GODINHO, R , MEGA, C , TEIXEIRA-DE-LEMOS, E , CARVALHO, E , TEIXEIRA, F , FERNANDES, R , REIS, F , (2015) THE PLACE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN TYPE 2 DIABETES THERAPEUTICS: A "ME TOO'' OR "THE SPECIAL ONE'' ANTIDIABETIC CLASS?.JOURNAL OF DIABETES RESEARCH. VOL. . ISSUE . P. - 209 86% 9
10 MCINTOSH, CHS , WIDENMAIER, S , KIM, SJ , (2009) GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GASTRIC INHIBITORY POLYPEPTIDE; GIP).VITAMINS AND HORMONES INSULIN AND IGFS. VOL. 80. ISSUE . P. 409 -471 276 72% 67

Classes with closest relation at Level 2


Rank Class id link
1 1896 METFORMIN//ACARBOSE//REPAGLINIDE
2 1415 DIPEPTIDYL PEPTIDASE IV//CD26//AMINOPEPTIDASE
3 457 BETA CELL//INSULIN SECRETION//PANCREATIC ISLETS
4 79 DIABETES CARE//DIABETES EDUCATOR//DIABETIC MEDICINE
5 972 GHRELIN//NEUROPEPTIDE Y//OBESTATIN
6 2027 PACAP//PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE//VIP
7 1300 THIAZOLIDINEDIONES//PPAR GAMMA//ROSIGLITAZONE
8 2404 HUMMINGBIRDS//SGLT1//NA ATPASE
9 2464 STREPTOZOTOCIN//KANGEN KARYU//HYPERCYTOLIPIDEMIA
10 763 PHYSIOLOGY & BEHAVIOR//FOOD INTAKE//CONDITIONED TASTE AVERSION

Go to start page